Viewing Study NCT04507061


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2025-12-25 @ 12:15 PM
Study NCT ID: NCT04507061
Status: COMPLETED
Last Update Posted: 2023-04-04
First Post: 2020-08-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module